ClinicalTrials.Veeva

Menu
P

Pantheon Clinical Research | Bountiful, UT

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Atogepant
KarXT
Maridebart Cafraglutide
Cariprazine
MET097
Ubrogepant
PF-08653944
Elismetrep
K-304

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

14 of 14 total trials

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Enrolling
Acute Migraine
Drug: Placebo
Drug: Elismetrep

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disea...

Enrolling
Alzheimer's Disease
Drug: Placebo
Drug: Xanomeline Enteric Capsule

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompa...

Enrolling
Chronic Migraine
Drug: Atogepant
Drug: Placebo for Atogepant

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling
Bipolar I Disorder
Depression
Drug: Placebo
Drug: Cariprazine

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vo...

Enrolling
Episodic Migraine
Drug: Placebo-Matching Atogepant
Drug: Atogepant

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with plac...

Enrolling
Migraine
Drug: Placebo
Drug: Elismetrep

The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an imm...

Enrolling
Alzheimer Disease
Agitation
Drug: KarX-EC
Drug: KarXT

The purpose of this clinical study is to learn about the safety and effects of the study medicine to help adults with obesity or overweight and type...

Active, not recruiting
Overweight and/or Obesity
Overweight
Drug: PF-08653944
Other: Placebo

This study investigates the efficacy and safety of once weekly injectable MET097 in adult participants with obesity or overweight with weight-related...

Active, not recruiting
Obesity and Overweight
Drug: Placebo
Drug: MET097

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Obesity
Drug: Placebo
Drug: Maridebart Cafraglutide

The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with o...

Enrolling
Overweight
Obesity
Drug: Maridebart cafraglutide
Drug: Placebo

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vo...

Invitation-only
Migraine Prophylaxis
Drug: Atogepant

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Invitation-only
Migraine
Drug: Ubrogepant

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea...

Enrolling
Migraine
Drug: Placebo-Matching Ubrogepant
Drug: Ubrogepant

Trial sponsors

AbbVie logo
Amgen logo
Bristol-Myers Squibb (BMS) logo
K
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems